Clinical Research

Primary Lung Malign Mesenchymal Tumors

Volume: 2 Number: 1 February 7, 2023
TR

Primary Lung Malign Mesenchymal Tumors

Abstract

Primary mesenchymal tumors are extremely rare tumors of the lung. Mesenchymal tumors constitute about 1% of all cancers and the most common sites are the extremities (59%). Their treatment and prognosis are limited because of their rare occurrence. In this study, three cases of primary lung mesenchymal tumor are presented in the light of the literature.

Keywords

References

  1. 1. Sundaresan SR, Ashrafi AS. Unusual Mediyastinal Tumors. In: Patterson GA, Cooper JD, Deslauriers J, Lerut AEMR, Rice TW, editors. Pearson’s Thoracic and Esophageal Surgery. 3rd ed. Philadelphia: Churchill Livingstone 2008;1641-52.
  2. 2. Etienne-Mastroianni B, Falchero L, Chalabreysse L. Primary sarcomas of thelung. A clinicopathologic study of 12 cases. Lung Cancer 2002;38:283-9.
  3. 3. Chhabra A, Soldatos T. Soft-tissuelesions: when can we exclude sarcoma? AJR Am J Roentgenol 2012;199(6):1345-57.
  4. 4. Suit HD, Spiro I. Role of radiation in the management of adult patients with sarcoma of soft tissue. Semin Surg Oncol 1994;10(5):347-56.
  5. 5. Zahm SH, Fraumeni JF Jr. The epidemiology of soft issue sarcoma. Semin Oncol 1997;24(5):504-14.
  6. 6. Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, Elashoff D. FDG-PET/CT imaging predict histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft tissue sarcomas. Clin Cancer Res 2009;15(8):2856-63.
  7. 7. Travis WD, Brambilla E, Müler-Hermelink HK, Haris C. Tumors of Pleura World Health Organization Classification of Tumors, Pathology and Genetics Tumours of the Lung, Pleura, Thymusand Heart, Lyon, IARC Pres, 2004;125-44.
  8. 8. Athanassiadi K, Kalavrouziotis G, Rondogianni D Loutsidis A, Hatzimichalis A, Bellenis I. Primary chest wall tumors: Early and long-term results of surgical treatment. Eur J Cardiothorac Surg 2001;19:589-93.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Clinical Research

Publication Date

February 7, 2023

Submission Date

December 28, 2022

Acceptance Date

January 10, 2023

Published in Issue

Year 2023 Volume: 2 Number: 1

APA
Kavas, M., Atinkaya Baytemir, C., Ersev, A., Öztürk, A., Derdiyok, O., Aydoğan Eroğlu, S., Alparslan Bekir, S., & Yalçınkaya, İ. (2023). Primary Lung Malign Mesenchymal Tumors. Istanbul Kent University Journal of Health Sciences, 2(1), 19-23. https://izlik.org/JA29HT77RY
AMA
1.Kavas M, Atinkaya Baytemir C, Ersev A, et al. Primary Lung Malign Mesenchymal Tumors. Istanbul Kent University Journal of Health Sciences. 2023;2(1):19-23. https://izlik.org/JA29HT77RY
Chicago
Kavas, Murat, Cansel Atinkaya Baytemir, Ayşe Ersev, et al. 2023. “Primary Lung Malign Mesenchymal Tumors”. Istanbul Kent University Journal of Health Sciences 2 (1): 19-23. https://izlik.org/JA29HT77RY.
EndNote
Kavas M, Atinkaya Baytemir C, Ersev A, Öztürk A, Derdiyok O, Aydoğan Eroğlu S, Alparslan Bekir S, Yalçınkaya İ (February 1, 2023) Primary Lung Malign Mesenchymal Tumors. Istanbul Kent University Journal of Health Sciences 2 1 19–23.
IEEE
[1]M. Kavas et al., “Primary Lung Malign Mesenchymal Tumors”, Istanbul Kent University Journal of Health Sciences, vol. 2, no. 1, pp. 19–23, Feb. 2023, [Online]. Available: https://izlik.org/JA29HT77RY
ISNAD
Kavas, Murat - Atinkaya Baytemir, Cansel - Ersev, Ayşe - Öztürk, Akın - Derdiyok, Onur - Aydoğan Eroğlu, Selma - Alparslan Bekir, Sümeyye - Yalçınkaya, İrfan. “Primary Lung Malign Mesenchymal Tumors”. Istanbul Kent University Journal of Health Sciences 2/1 (February 1, 2023): 19-23. https://izlik.org/JA29HT77RY.
JAMA
1.Kavas M, Atinkaya Baytemir C, Ersev A, Öztürk A, Derdiyok O, Aydoğan Eroğlu S, Alparslan Bekir S, Yalçınkaya İ. Primary Lung Malign Mesenchymal Tumors. Istanbul Kent University Journal of Health Sciences. 2023;2:19–23.
MLA
Kavas, Murat, et al. “Primary Lung Malign Mesenchymal Tumors”. Istanbul Kent University Journal of Health Sciences, vol. 2, no. 1, Feb. 2023, pp. 19-23, https://izlik.org/JA29HT77RY.
Vancouver
1.Murat Kavas, Cansel Atinkaya Baytemir, Ayşe Ersev, Akın Öztürk, Onur Derdiyok, Selma Aydoğan Eroğlu, Sümeyye Alparslan Bekir, İrfan Yalçınkaya. Primary Lung Malign Mesenchymal Tumors. Istanbul Kent University Journal of Health Sciences [Internet]. 2023 Feb. 1;2(1):19-23. Available from: https://izlik.org/JA29HT77RY